We're proud to share the recent article in Pharmaceutical Executive where Dea Belazi, CEO AscellaHealth provides his key insights on how emerging technologies are increasingly impacting patient care management. Read more here: https://lnkd.in/eyZasxGs #specialtypharmacy #patientcare #patientengagement #FollowAscellaHealth
About us
AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex, chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Our end-to-end specialty pharmacy services support all specialty disease states and include, Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics via our proprietary technology platform. AscellaHealth is at the forefront of the Specialty Pharmacy industry and has proactively developed a customizable suite of services and programs based on shifting trends and market conditions within the specialty pharmacy industry. We are your premier partner in Specialty Pharmacy and Healthcare solutions for improving access, optimizing outcomes, and enhancing the patient journey.
- Website
-
http://www.ascellahealth.com/
External link for AscellaHealth
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Berwyn, Pennsylvania
- Type
- Partnership
- Founded
- 2013
- Specialties
- Specialty Pharmacy, Mail Order Pharmacy, Claims Processing, Formulary Development, Long Term Care, Superior Reporting & Analytics, Medicare Part D, Clinical Programs, Customized Retail Networks, Prior Authorization, Rebate Management, Benefit Design/ Consulting, Market Access, Pre-Commercialization, Pharmaceutical Consulting, Healthcare Services, Supply Chain Logisitics, HUB Services, Patients Support Services , Distribution & Fulfillment , Payer Solutions , Pharma Financials Programs , Co-pay Assistance, Wholesale, 3PL, Data and Analytics, Custom Clinical Programs , and Patient Engagement
Locations
-
Primary
Get directions
1055 Westlakes Dr
Berwyn, Pennsylvania 19312, US
Employees at AscellaHealth
Updates
-
As we prepare for future recordings of AscellaHealth's Podcast Pulse, we want to hear from you. Please take a moment to provide your input. #AscellaHealthPodcastPulse #Healthcare #AIinHealthcare #Biosimilars #HealthTech #PatientAdvocacy #CellandGeneTherapies #HealthcareInnovation
This content isn’t available here
Access this content and more in the LinkedIn app
-
Clinical trial delays could cost manufacturers up to $8 million a day. Manufacturers are pressured to make global clinical trials faster, less expensive and more accurate without compromising quality or integrity. Discover how to tailor your clinical trial to maximize your budget and ensure launch success. Read AscellaHealth's latest newsletter now: https://lnkd.in/eFYmkDuD #clinicaltrials #pharmaceutical #drugdevelopment #patientcare #specialtypharmacy
-
Explore AscellaHealth’s Q2 Specialty & Rare Pipeline Digest featuring the latest updates on recent specialty drug approvals, upcoming reviews, #CGT and biosimilar pipelines. If you haven’t already, make sure to subscribe to one of the most comprehensive resources available today: https://lnkd.in/eXTyz2gx #specialtypharmacy #pharmaceuticals #raredisease #FollowAscellaHealth #biopharma
AscellaHealth Releases Q2 2024 Specialty & Rare Pipeline Digest™: Increased Approvals Signal Growing Demand and Utilization of Specialty Pharmaceuticals
businesswire.com
-
Congratulations to Mario A. Patone CFO, AscellaHealth for officially being recognized as one of Greater Philadelphia’s distinguished business executives during Philadelphia Business Journal's Corporate Leadership Award Program held on July 11th! Read more: https://lnkd.in/eGYNa-vS
Corporate Leadership Awards 2024: Mario Patone, AscellaHealth - Philadelphia Business Journal
bizjournals.com
-
AscellaHealth is at the forefront of combining digital technology with personalized support to streamline the patient journey. With innovations in telehealth, remote monitoring, and patient education, we're overcoming barriers to access and empowering patients worldwide. Explore the full article: https://lnkd.in/gsXKpGHs #Healthcare #ChronicConditions #DigitalInnovation #PatientSupport #AscellaHealth #HealthTech
-
-
Wishing you a safe and spectacular Fourth of July from the AscellaHealth Team! #HappyIndependenceDay #Happy4th #fourthofjuly2024 #July4th
-
-
We’re excited to announce that Optime Care Specialty Pharmacy, an AscellaHealth Company, has launched another branded pharmaceutical program, providing its comprehensive suite of integrated patient management and HUB services, enhancing outcomes for patients throughout the treatment journey. #specialtypharmacy #marketaccess #commercialization #hubservices #pharmaceutical #rarediseases Read more here: https://lnkd.in/e3t7xAEy
Optime Care Announces Enhanced Partnership with Rigel Pharmaceuticals for GAVRETO® Patients
businesswire.com
-
We’re happy to share the recent coverage of Medhealth Outlook, where they named AscellaHealth a 2024 Top Life Science Solution Provider and featured Dea Belazi, CEO, AscellaHealth, providing his insights on how our patient-centric approach and tailored solutions optimize outcomes for patients, drive commercialization success and reduce costs for clients. Read more here: https://lnkd.in/emCHGrhe #specialtypharmacy #pharmaceutical #patientfocused
Pharma and Life Science Edition 2024 - Medhealth Outlook
https://medhealthoutlook.com
-
We're excited to announce that Mario A. Patone CFO, AscellaHealth has been recognized as one of Greater Philadelphia's distinguished business executives in the Philadelphia Business Journal's Corporate Leadership Awards and will be honored at the July 11th award program. Congratulations to Mario and all other honorees! Read more in the release here: https://lnkd.in/e8A8cZ9D #Philadelphia #CFO #AscellaHealth
Philadelphia Business Journal Features AscellaHealth CFO Mario Patone in Corporate Leadership Awards
businesswire.com